{"id":"NCT00925301","sponsor":"Amicus Therapeutics","briefTitle":"Study of the Effects of Oral AT1001 (Migalastat Hydrochloride) in Patients With Fabry Disease","officialTitle":"A Double-Blind, Randomized, Placebo-Controlled Study to Evaluate the Efficacy, Safety and Pharmacodynamics of AT1001 in Patients With Fabry Disease and AT1001-Responsive GLA Mutations","status":"COMPLETED","phase":"PHASE3","dates":{"start":"2009-10-23","primaryCompletion":"2012-06-12","completion":"2014-01-29","firstPosted":"2009-06-22","resultsPosted":"2018-10-30","lastUpdate":"2018-10-30"},"enrollment":67,"design":{"allocation":"RANDOMIZED","model":"PARALLEL","masking":"DOUBLE","primaryPurpose":"TREATMENT"},"conditions":["Fabry Disease"],"interventions":[{"type":"DRUG","name":"migalastat hydrochloride","otherNames":["AT1001","Galafold","Migalastat"]},{"type":"DRUG","name":"Placebo","otherNames":[]}],"arms":[{"label":"Migalastat","type":"EXPERIMENTAL"},{"label":"Placebo","type":"PLACEBO_COMPARATOR"}],"summary":"The primary objective of this study was to compare the effect of migalastat (123 milligrams \\[mg\\] of migalastat \\[equivalent to 150 mg of migalastat hydrochloride\\]) (migalastat) versus placebo on kidney globotriaosylceramide (GL-3).","primaryOutcome":{"measure":"Percentage Of Participants With At Least A 50% Reduction From Baseline To Month 6 In The Average Number Of Kidney Interstitial Capillary (IC) Globotriaosylceramide (GL-3) Inclusions","timeFrame":"Baseline, Month 6","effectByArm":[{"arm":"Migalastat","deltaMin":13,"sd":null},{"arm":"Placebo","deltaMin":9,"sd":null}],"pValues":[{"comp":"OG000 vs OG001","p":"0.2996"}]},"eligibility":{"minAge":"16 Years","sex":"ALL","healthyVolunteers":false,"inclusionCount":7,"exclusionCount":6},"locations":{"siteCount":28,"countries":["United States","Argentina","Australia","Brazil","Canada","Denmark","Egypt","France","Italy","Poland","Spain","Turkey (TÃ¼rkiye)","United Kingdom"]},"refs":{"pmids":["32994552","30723321","29703262","27657681","27509102"],"seeAlso":[]},"adverseEventsSummary":{"seriousAny":{"events":2,"n":34},"commonTop":["Headache","Nasopharyngitis","Paraesthesia","Fatigue","Upper Respiratory Tract Infection"]}}